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Serum amyloid A (SAA)' is a family of acute phase proteins (1-3), unique
among these in being an apoprotein of high density lipoprotein (HDL) (4, 5). In
response to a variety ofinflammatory conditions, plasma SAA levels are dramat-
ically elevated several hundred to a thousandfold and may reach a concentration
of 1 mg/ml (6-8). The various inflammatory stimuli are thought to elevate SAA
via a common monocyte-derived circulating mediator (9). IL-1 has been identi-
fied as one such mediator (10-16). In the mouse, SAA is encoded by three genes
(SAA1, SAA2, and SAA3) and a pseudo gene (17). The liver is a major site of
SAA synthesis where messenger RNA for each of the three genes is elevated
500-2,000-fold after LPS injection (18, 19). The SAA, and SAA2 polypeptides
are synthesized and secreted by hepatocytes (20-22) and constitute as much as
20% of the HDL apoprotein of mice challenged with LPS (23). The SAA3 gene
is a recent discovery (2), and identification of the polypeptide has not yet been
reported.
SAA is perhaps more widely known as the precursor to amyloid A (AA)
protein. It is the major component of amyloid fibrils deposited in tissues in the
disease amyloidosis associated with chronic inflammation (4, 5, 24-27). Of the
three possible SAA gene products, murine AA protein is derived from only
SAA2 (9) by a mechanism that selectively removes it from the circulating pool of
both SAA, and SAA2 (22). Though liver is considered to be the major ifnot the
only source of SAA, some reports (28-30) have suggested extrahepatic sites of
synthesis, particularly the spleen, and that deposit of AA in amyloidosis is
mediated via local synthesis. Using a murine SAA cDNA, we have previously
shown (22) that the spleen is not active in synthesizing SAA mRNA during
splenic amyloid deposit induced by repeated casein injections in mice. We wished
to determine ifthe three individual members ofthe SAA gene family in the liver
respond to inflammation induced by different inflammatory agents and ifany of
the SAA genes are expressed in extrahepatic tissues. We found differential
hepatic SAA response to these agents; casein elevated hepatic SAA, and SAA2
niRNA while LPS elevated all three. Extrahepatic SAA mRNA was also found,
primarily after LPS injection, and several qualitative and quantitative patterns
of SAA1, SAA2, and SAA3 mRNA expression are evident among these tissues.
It is clearthat the SAA gene family does not exhibit a simple all-or-none response
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to casein- or LPS-induced inflammation but exhibits a diverse expression of
individual members of the family ; this varies among tissues and between the two
inflammatory agents used .
Materials and Methods
RNA Preparation and Northern Blot Analysis.
￿
Male BALB/c mice 2-3 mo of age were
given an intraperitoneal injection of LPS (50 gg in 0.5 ml of PBS) or a subcutaneous
injection of casein (0 .5 ml ofa 10% solution). 18 h after injection, animalswere killed and
we removed the appropriate tissues. Peritoneal macrophages were elicited by injecting 2
ml of sterile thioglycolate intraperitoneally. 2 d later we injected 10 ug of LPS intraperi-
toneally, and after another day cells were collected by peritoneal lavage, washed in PBS,
and plated in petri dishes at 2 x 106 cells/60-mm dish in RPMI medium containing 20%
FCS. After I h, attached cells were washed and scraped from the plates in PBS and
pelleted for RNA extraction. Liver for time course data was obtained from BALB/c mice
after LPS injection and CBA mice after casein injection. Total RNA was isolated from
fresh tissues or cells after polytron homogenization in 5 M guanidinium isothiocyanate
and LiCl precipitation (31) as described elsewhere (32). RNA was denatured and electro-
phoresed through 1 .5% agarose containing 2.2 M formaldehyde (33) and transferred to
Gene Screen Plus nylon membrane (New England Nuclear, Boston, MA) (34). Blots were
incubated in hybridization solution (35) modified to include salmon sperm DNA (20-40
wg/ml) and polyethylene glycol 6000 (10%). After 3-4 hr blots were hybridized with 1 x
10' cpm/ml of nick-translated 32P-labeled SAA cDNA (36) for 16 hr at 42°C, washed as
described previously (14), and exposed to X-ray film (Kodak XAR-5) at -70°C apposed
to an intensifying screen (Dupont Cronex lightning plus).
Oligonucleotide Probes.
￿
To distinguish between SAA,, SAA2, and SAAB mRNA, oli-
gonucleotide probes specific for each were synthesized (courtesy of Howard Hughes
Medical Institute, DNASynthesis Laboratory, University of Washington). Allthree probes
were designed from a region in the 3' untranslated sequences beginning 14 nucleotides
after the termination codon where all three genes are divergent (3), as shown in Fig. 2a;
these are distinct from the oligonucleotides used by Yamamoto et al. (37). Uniqueness of
each oligonucleotide for their respective mRNA was checked by searching each of the
three SAA mRNA sequences for regions of homology to each of the oligonucleotide
sequences(Sequence Homology Search Program, International Biotechnologics Inc., New
Haven, CT). Oligonucleotides were end-labeled with T4 polynucleotide kinase (Bethesda
Research Laboratories, Gaithersburg, MD) following the manufacturer's directions, ex-
cept that 10 pmol of oligonucleotide were reacted in a lO-Al reaction with 50 ACi ['y"P]
ATP (3,000-4,000 Ci/mmol). Oligonucleotides were separated from unincorporated
[y"P]ATP by chromatography through P-10 resin (Bio-Rad Laboratories, Richmond,
CA) in 10 mM Tris (pH 7.5), 100 mM NaCl, 2 mM EDTA, 10 kg/ml yeast tRNA (32).
Probe-specific activity of 2-4 x 106 cpm/pmol was regularly obtained, assuming 100%
recovery of oligonucleotide.
Denaturing gel electrophoresis and blotting analysis was performed as described above.
Prehybridization was performed in 6X SSC (IX = 105 mM NaCl, 15 mM Na citrate), 5X
Denhardt's solution, 0.5% SDS, 100 ,ug/ml yeast tRNA, and 0.05% NaPP at 45°C for 1-
4 h. End-labeled oligonucleotide probes were heated at 65°C for 5 min, diluted to 3-5
ng/ml in hybridization solution (as above except with 0.1 % SDS). Blots were hybridized
with oligonucleotide for 16 h at 45°C, then washed at room temperature in 6X SSC,
0.1 % SDS three times for 20 min followed by one wash at 45'C for 5 min. Autoradiog-
raphy was then carried out as described above.
The melting temperature (Tfor SAA, and SAA2 oligonucleotide is 52 °C, while that
of the SAA., oligomer is 54°C (38). For oligomer hybrids <20 nucleotides long, the T, is
reduced 5°C for each mismatched base pair. SAA, and SAA2 probes are mismatched at
4 positions, while the SAA3 probed is mismatched at 12 and 13 positions compared with
complimentary regions of the SAA, and SAA2 probes, respectively. Therefore, hybridi-
zation was performed at 45'C, which is 7°C below the T, of SAA, and SAA2 oligomers2008
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FIGURE 1 .
￿
Representative Northern blot ofSAA mRNA in several mouse tissues . (a) 5 tag
of total RNA from each tissue, except 0.5 tag of liver RNA, 18 h after injection with casein or
LPS, were denatured, electrophoresed, blotted, and hybridized with "P-labeled SAA cDNA
as described under procedures : (1) unstimulated; (2) casein ; (3) LPS . A typical autoradiograph
is shown . (b) As in a except the autoradiograph exposure was three times longer, and (1)
unstimulated ; (2) LPS .
and only 2 °C below the temperature recommended for perfectly matched molecules (38) .
Under these conditions, each oligonucleotide probe should hybridize specifically to their
respective mRNAs. Evidence of the specificity of these probes is seen in Fig . 3, where the
pattern of expression is distinctly different among most tissues .
Results
The relative amount of SAA mRNA in 14 murine tissues was examined after
casein or LPS injection by hybridization of Northern blots with recombinant
mouse SAA, cDNA . The resultant pattern of SAA mRNA expression after
casein injection is quite different from the pattern after LPS injection (Fig . 1) .
Casein stimulated ^-1,000-fold elevation of hepatic SAA mRNA compared with
uninjected controls (Table I) . Of the remaining 13 tissues, casein induced SAA
mRNA elevation only in the adrenal gland . SAA mRNA was detected in small
and large intestine, but at a level equivalent to the unstimulated quantity . In
contrast to the limited effect of casein on tissues, LPS elicited SAA mRNA
accumulation in all tissues examined (Table I) . As with casein injection, liver was
stimulated ^" 1,000-fold after LPS injection . Extrahepatic tissues exhibit a broad
range ofSAA levels from trace amounts in pancreas and brain to modest amounts
in the large intestine, kidney, and lung. A more detailed examination of small
intestines revealed a gradient of response to LPS (Fig . 1) ; only trace amounts
could be detected in the duodenum, while the jejunum contained ^-0.5% and
ileum ^-5% of hepatic levels (Table I) . Three major regions of the brain were
also examined for differential SAA mRNA levels (cerebrum, cerebellum and
pons, medulla and stem), and were found to express equal levels ofSAAmRNA
(data not shown) .
We used separate oligonucleotide probes designed from the 3'-untranslated
portion of each SAA messenger RNA (Fig . 2 a) to assess the specific SAA,, SAA2 ,MEEK AND BENDITT
TABLE I
Relative Levels ofMouse SAA mRNA Induced by LPS or Casein
Total RNA wasprepared from individual tissues, except pituitary andadrenal
glands which were pooled from 6-10 animals. 5 Ag of RNA were examined by
Northern blot analysis. Filters were hybridized with s2P-labeled SAA cDNA as
in Fig. 1. Each filter contained 5, 0.5, 0.05, and 0.005 tcg of 18-h post-LPS
total liver RNA as standards. Various exposures of the resulting autoradi-
ographswere analyzed by quantitative scanning densitometry. Absorbances in
the linear range of the film exposure were compared with absorbances of the
liver RNA standards. Relative values are expressed as percentof that foundin
18-h post-LPS liver RNA. The5' endofour SAA, cDNA (pSAA,) contains a
highly conserved region (100%) spanning amino acid residues 32-44 (3, 17)
and represents 12% of pSAA, length . The remaining pSAA, sequence 3' to
this conserved sequence is ^-45% homologous to SAAB but >90% homologous
to SAA2 mRNA. Only nick-translated SAA, cDNA fragments complementary
to the highly conserved region of SAAB mRNA will be stable under the
hybridization and wash conditions used. Therefore SAAB mRNA is detected
with ^-12% the sensitivity of SAA, and SAA2 mRNA.
* Plasmid pSAA, could detect mRNA in as little as 2.5 ng of total RNA from
mouse liver 18 h after injection of LPS. This represents ^-3 SAA,, 3 SAA2,
and 24 SAAB mRNA molecules per hepatocyte, assuming 6,000 molecules of
each SAA mRNA per hepatoycte as reported by Lowell (18), and establishes
the lower limits of SAA mRNA detection in these experiments.
These data were determined from one set of tissues. RNA from most tissues
has been isolated in one more or up to three more experiments with similar
results.
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or SAA3 mRNA expression in hepatic and extrahepatic tissues. The time course
of liver mRNA expression for SAA1, SAA2, and SAA3 after casein or LPS
injections are shown in Fig. 2 b. SAA, and SAA2 mRNAs exhibit essentially the
same time course after a single casein injection; they were only slightly elevated
by 4 h (3%), followed by a gradual rise to -25%s of the maximum level by 9 h.
The maximum level was reached by 16 h, where they remained through 29 h.
SAA3 mRNA was minimally elevated by casein injection and reached only 3%
of the maximum SAA, and SAA2 levels. The accumulation of SAA, and SAA2
mRNA after LPS injection was much more rapid than after casein injection.
They were both near maximal elevation by 4 h (90%) and remained elevated up
to 29 h when the levels began to decline (70%). At 48 h, SAA, and SAA2 mRNA
were -15% of the maximum level after 9 and 16 h. The SAA3 mRNA was
expressed at a high level compared with casein injection, but accumulated at a
Tissue
Control
Treatment
Casein LPS
Liver 0.1 100 100
Adrenal 0 0.5 2.0
Large intestine 1.5 1.0 9.0
Small intestine 0.2 0.2 1.0
Duodenum 0 ND 0
Jejunum 0.1 ND 0.5
Ileum 0.5 ND 5.0
Kidney 0 0 5.0
Lung 0 0 2.5
Testes, skeletal muscle,stomach, spleen, 0 0 0.05*-0.5
heart, pancreas, brain, pituitary2010
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FIGURE 2 .
￿
Hepatic SAA,,SAA2 , andSAABmRNA detected with oligonucleotide probes . (a)
Nucleotide sequences of SAA,, SAA2 , and SAAB message-strand DNA (reference 3) from
whichcomplementary oligonucleotide probes were designed . (b)Time course of hepatic SAA,,
SAA2 , and SAAB mRNA accumulation after LPS or casein injection . Mice received a single
injection of LPS or casein and total RNA was isolated at the indicated times from individual
livers after LPS injection or from pairs of livers after casein injection . Filters were hybridized
with 12P-labeled oligonucleotide probes as described under Materialsand Methods . A repre-
sentative autoradiograph is shown . Quantitative densitometry of several autoradiographs was
performed as in Table I, and absorbances were calculated relative to the density of liver RNA
16 h after LPS injection .
slower rate than that of LPS-induced SAA, and SAA2, reading 25% of the
maximum level at 4 h, 50% by 9 h, and the maximum equal to SAA2 by 16 h;
disappearance is slightly faster than that of SAA, and SAA2 mRNA so that by
48 h the level is reduced to 3% . The different rate of SAA, and SAA2 mRNA
accumulation induced by casein compared with LPS injection was also observed
in the time course of SAA accumulation in the circulation determined by RIA
in groups of four animals at each point (data not shown) .
Analysis of extrahepatic tissue also revealed distinct patterns ofSAA,, SAA2 ,
and SAAB gene expression (Fig . 3) . The tissues can be grouped into three
patterns (Table 11) : (a) tissues expressing all three genes (liver and kidney), (b)
tissues expressing SAA, and SAA3 (small and large intestine), and (c) tissues that
express predominantly or only SAA3 (adrenal gland, lung, spleen, heart, testis,
stomach, skeletal muscle, brain, pituitary gland, pancreas, peritoneal macro-
phages) . Liver and kidney express all three mRNAs with the liver exhibitingMEEK AND BENDITT
￿
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FIGURE 3 .
￿
Representative Northern blot of SAA,,SAA2,and SAAB mRNAin severalmouse
tissues 18 h after LPS injection . 20,ug of total RNA from each tissue, and 0.2,ug (lane 1) and
2 jig (lane 2) of liver were analyzed as described in Fig. 2 .
nearly equal amounts of each one . In the kidney, all SAA mRNAs were lower
than liver and exhibit a distinct fourfold difference between SAA, (20%) and
SAA2 (5%) (Table II) . SAA2 was not detected in the small or large intestine,
while SAA, was low and SAA3 substantial . Analysis of the duodenum, jejunum,
and ileum revealed a different quantitative pattern for SAA, and SAA3 expres-
sion (Table I1) . SAA3 levels varied by only approximately threefold between
them, but SAA, was very prominent in the ileum, being 10-fold higher than in
jejunum and not detected at all in duodenum . Of the remaining tissues, lung
and adrenal gland expressed high levels ofSAA3 (60 and 35%) and low levels of
SAA, and SAA2 . Low levels ofSAA 2 were found in skeletal muscle and stomach
while SAA3 levels were moderate and SAA, was not detected . SAA, and SAA2
mRNA was not detected in the remaining tissues, but we found different levels
of SAA3 : peritoneal macrophages, 100% ; testis, heart, and spleen, 25-35% ; and
pancreas and brain 1-2% of hepatic levels .
Discussion
The differences in tissue expression of the three SAA mRNAs, the different
time course in liver, and the differing tissue response to specific acute-phase
stimulants raise a new set of questions about the mode of regulation at the
molecular level ofthis family ofgenes and the possible functions oftheir products .
A variety of stimuli, including tissue injuryand inflammatory agents, are effective
in elevating SAA levels . The different stimuli are thought to act at least in part201 2
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TABLE II
Relative Levels ofSAA,, SAA2 and SAA3 mRNA in Different Tissues after Casein
or LPS Injection
Treatment
20 Ag of total RNA from each tissue or 2 Ag of macrophage RNA were examined by Northern
blot analysis as in Fig. 3. Autoradiograph exposures in the linear response range were examined
by quantitative densitometry andabsorbances were compared with those of standards constructed
with total post-LPS (I8-h) liver RNA as described for TableI.
* These tissues do not respond to casein.
$ Values are relative to total liver RNA 18 hr after LPS injection.
§ Lowest detectable SAA mRNA levels correspond to 30 molecules/heptocyte, assuming 6,000
molecules of each SAA mRNA per hepatocyte (18).
through a common macrophage/monocyte-derived mediator or mediators (14,
16, 21); IL-1 has been identified as a mediator of SAA induction (10-13).
Whether monokines besides IL-1 are involved in SAA production is not known.
The data reported here indicate that there is more than one factor responsible
for the induction of the several SAA genes. The most notable fact is that SAA3
gene expression is different from SAA, and SAA2. Thus hepatic SAA3 mRNA
is expressed at high levels in response to LPS but is expressed only at a low level
after casein administration . Moreover, the majority of extrahepatic tissues re-
spond only to LPS and then mainly with expression of SAA3 mRNA. Besides IL-
1, macrophages and monocytes secrete other monokines, including lymphotoxin,
IFN-y, tumor necrosis factor, and glucocorticoid-antagonizing factor in response
to bacterial infection or endotoxin administration (39, 40). Perhaps one or
several of these factors is involved in control of SAA3 mRNA expression.
SAA3 RNA is expressed in a wide variety of tissues at levels ranging over 100-
fold between liver and brain (Table II). This differential behavior raises the
following question: are the differentiated cells of these tissues responsible for
SAA3 mRNA expression or is it expressed by a single dispersed cell system
present in these tissues? For this role there are several candidate cells: (a)
endothelial or (b) smooth muscle cells of the vasculature, or (c) resident tissue
Tissue
SAA,
Casein
SAA2 SAAB SAA,
LPS
SAA2 SAAB
Liver 100 100 2 100$ 100 100
Kidney* 20 5 11
Large intestine* 1 0 0 4.5 0 25
Small intestine* 0.5 0 0 1 0 10
Duodenum 0 0 3
Jejunum I 0 7
Ileum 15 0 10
Adrenal 0 0 2 1 2 35
Lung* 1 0.5$ 60
Spleen* 0 0 25
Heart* 0 0 30
Testis* 0 0 12
Skeletal muscle* 0 1 8
Stomach* 0 0.5 7
Brain,* pituitary,* pancreas* 0 0 1
Macrophages* 0 0 100MEEK AND BENDITT
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macrophages. We found after LPS stimulation that RNA from peritoneal mac-
rophages contain as much SAAB mRNA as that found in liver RNA (Table II);
moreover, thioglycollate-elicited macrophages did not express elevated SAA
mRNA in response to casein (data not shown), as is the case with all extrahepatic
tissue except adrenal gland. Fixed macrophages may be responsible for produc-
tion of the SAAB mRNA in some tissues like lung, but in others, heart and testis
for example, this seems unlikely because the macrophage population is low, while
SAAB levels are quite substantial. It is also of interest that endothelial cells
elaborate a variety of inflammatory mediators including IL-1 in response to LPS
(41). Could they also express SAAB? Whether tissue macrophages and other
members of the reticuloendothelial system express SAAB mRNA in response to
LPS and whether they alone are responsible for extrahepatic tissue SAAB mRNA
remains to be determined.
The small intestine is interesting; the SAA_, level varied only threefold over its
length after LPS injection, while SAA, was expressed most dramatically in the
ileum (Table II). In addition, SAA, mRNA was detected in control ileum and
large intestine. Perhaps the presence of gram-negative bacteria and their pro-
duction of endotoxin in these regions of the intestinal tract cause SAA, expression
in otherwise unstimulated control animals and this is only moderately enhanced
after LPS injection.
A recent report by Ramadori et al. (42) using a cDNA common to all three
SAA mRNAs showed accumulation of SAA mRNA in the spleen after LPS
injection. The authors suggested local production of SAA as a source of AA
protein. However, this is not the case since murine AA protein is derived from
only the SAA2 polypeptide (9) and the spleen expresses only the SAA_, mRNA
(Table II). Furthermore, in a previous report (22) no SAA mRNA was detected
in the spleen during casein-induced splenic amyloid accumulation.
Our finding that hepatic SAA_, mRNA reached a level equivalent to that of
SAA, and SAA2 mRNA after LPS injection differs from the data of Yamamoto
et al . (37). They reported that SAA_, mRNA was barely detectable while SAA,
and SAA2 mRNA were expressed at high levels. The reason for this discrepancy
is not clear. Perhaps this discrepancy is a result of the different sets of oligonu-
cleotide probes used or because Yamamoto et al. analyzed RNA levels 24 h after
LPS injection when the SAA_, mRNA levels were declining.
The widespread pattern of tissues expressing SAA_, messenger RNA resembles
that of apoE mRNA expression (43), while the pattern ofSAA, and SAA2 mRNA
expression resembles more closely the restricted pattern of A-1 mRNA (44).
Differences in tissue expression and gene responses to acute-phase stimuli suggest
that SAA_, may have a different function from that of the SAA, and SAA2.
Structural evidence points to SAA, and SAA2 having a selective affinity for
certain lipids, as indicated by their association with particular lipoprotein sub-
classes (20, 23). Is it possible that SAA_, also has a special affinity for certain
lipids? We have not yet found, nor have others reported, evidence of SAA_,
protein in the circulation ; perhaps the SAA_, polypeptide remains cell bound. Of
interest is the fact that the putative SAA_, signal peptide (3) contains a core region
of hydrophobic and uncharged residues like other signal peptides (45); however,
it contains glutamine at position -1, a very unusual amino acid at this position .2014
￿
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In addition, the putative signal peptide cleavage site has a low processing
probability (46). If SAAB is not secreted, it could be involved with intracellular
lipid and other lipophilic substance transport.
The present study provides information on the variety of tissues capable of
synthesizing SAA mRNAs and the differential expression of the three murine
SAA genes. Further studies are necessary to: (a) identify the cell type(s) respon-
sible for extrahepatic SAA mRNA synthesis, particularly SAAB; (b) determine
whether SAAB is secreted or remains intracellular as a first step in elucidating its
function; and (c) elucidate the mechanisms and determine the factors involved
in the control ofSAA,, SAA2, and SAA3 mRNA expression .
Summary
Serum amyloid A (SAA) is a major acute-phase reactant and apoprotein of
high density lipoprotein (HDL). SAA is encoded by a family of three active
genes. We examined hepatic expression and searched forextrahepatic expression
of the three SAA mRNAs after injection with casein or LPS. Studies using an
SAA cDNA, which detects all three SAA mRNAs, revealed that after casein
injection liver SAA mRNA was elevated 1,000-fold. Adrenal gland expressed
SAA mRNA at a low level (0.5% of hepatic level), and was the only extrahepatic
tissue with elevated SAA mRNA after casein injection. The small intestine,
primarily the ileum, and the large intestine of unstimulated control animals
contained 5- and 15-fold higher SAA mRNA levels than control liver. LPS also
elevated liver SAA mRNA ^-1,000-fold. However, in contrast to casein injection,
every extrahepatic tissue examined expressed SAA mRNA . Lung and kidney
contained 2-5% and large intestine contained nearly 10% ofSAA mRNA levels
found in liver RNA. SAA mRNA levels were lower in the remaining tissues and
ranged from 0.1% in the brain and pancreas to 1.0% in the small intestine, with
the ileum containing 50-fold more than the duodenum.
Analysis ofliver with SAA,, SAA2, and SAA3 mRNA-specific oligonucleotide
probes revealed that SAA, and SAA2 mRNA were elevated ^-50-fold higher
than SAA3 mRNA after casein administration. LPS, however, induced all three
SAA mRNAs equally. In extrahepatic tissues, SAA,, SAA2, and SAA3 mRNAs
were expressed differentially and can be grouped into three general classes: (a)
tissues expressing all three genes, (b) tissues expressing SAA, and SAA3, and (c)
tissues expressing predominantly or only SAA3.
We thank Marlene Wambach for technical assistance, Ginny Wejak for manuscript
preparation, and Tom Barrett and Paul Haydock for helpful comments.
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